The burgeoning popularity of tirzepatide , initially for blood sugar control , is creating significant interest within the UK , prompting a notable shift in medication trends. Access these compounds remains a complex challenge , with public healthcare system coverage currently limited and private clinics offering treatment at a higher cost . Concer